Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMC 1864955)

Published in Mol Microbiol on March 01, 2007

Authors

Amy J Reese1, Aki Yoneda, Julia A Breger, Anne Beauvais, Hong Liu, Cara L Griffith, Indrani Bose, Myoung-Ju Kim, Colleen Skau, Sarah Yang, Julianne A Sefko, Masako Osumi, Jean-Paul Latge, Eleftherios Mylonakis, Tamara L Doering

Author Affiliations

1: Department of Biological Sciences, Cedar Crest College, Allentown, PA 18104-6196, USA.

Articles citing this

The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97

Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog (2010) 1.66

The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev (2012) 1.45

How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol (2009) 1.43

Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell (2007) 1.36

Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses. MBio (2013) 1.20

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med (2014) 1.18

Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genet Biol (2009) 1.07

Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot Cell (2007) 1.05

The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot Cell (2007) 1.05

Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun (2009) 1.04

Fission yeast Ags1 confers the essential septum strength needed for safe gradual cell abscission. J Cell Biol (2012) 1.03

KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans. Mol Microbiol (2010) 1.01

Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol Microbiol (2011) 1.01

Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host. Eukaryot Cell (2010) 1.00

Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans. Eukaryot Cell (2009) 0.99

Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactions. PLoS One (2010) 0.98

Emerging themes in cryptococcal capsule synthesis. Curr Opin Struct Biol (2011) 0.96

Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Delta mutant. Infect Immun (2007) 0.93

The still obscure attributes of cryptococcal glucuronoxylomannan. Med Mycol (2009) 0.92

Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection. J Immunol (2012) 0.90

The F-Box protein Fbp1 regulates sexual reproduction and virulence in Cryptococcus neoformans. Eukaryot Cell (2011) 0.87

Functional analysis of the α-1,3-glucan synthase genes agsA and agsB in Aspergillus nidulans: agsB is the major α-1,3-glucan synthase in this fungus. PLoS One (2013) 0.87

Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infect Immun (2011) 0.87

Beta-glucan: an ideal immunostimulant in aquaculture (a review). Fish Physiol Biochem (2012) 0.87

Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Eukaryot Cell (2012) 0.86

A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans. Mol Microbiol (2012) 0.85

α1,3 glucans are dispensable in Aspergillus fumigatus. Eukaryot Cell (2011) 0.85

In good company: association between fungal glycans generates molecular complexes with unique functions. Front Microbiol (2012) 0.85

Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans. MBio (2014) 0.84

Deletion of the α-(1,3)-glucan synthase genes induces a restructuring of the conidial cell wall responsible for the avirulence of Aspergillus fumigatus. PLoS Pathog (2013) 0.84

A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. Fungal Genet Biol (2012) 0.81

A Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic Outcome. PLoS Pathog (2015) 0.81

Biochemical characterization of Paracoccidioides brasiliensis α-1,3-glucanase Agn1p, and its functionality by heterologous Expression in Schizosaccharomyces pombe. PLoS One (2013) 0.80

Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly. Eukaryot Cell (2014) 0.79

Neurospora crassa 1,3-α-glucan synthase, AGS-1, is required for cell wall biosynthesis during macroconidia development. Microbiology (2014) 0.78

Pleiotropic effects of deubiquitinating enzyme Ubp5 on growth and pathogenesis of Cryptococcus neoformans. PLoS One (2012) 0.78

Intracellular Action of a Secreted Peptide Required for Fungal Virulence. Cell Host Microbe (2016) 0.77

Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans. Fungal Genet Biol (2014) 0.77

Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. Future Microbiol (2014) 0.76

Physiological Differences in C. neoformans in vitro versus in vivo and Their Effects on Antifungal Susceptibility. Antimicrob Agents Chemother (2016) 0.75

Cryptococcus neoformans UGT1 encodes a UDP-Galactose/UDP-GalNAc transporter. Glycobiology (2016) 0.75

Discovery and Characterization of a Peptoid with Antifungal Activity against Cryptococcus neoformans. ACS Med Chem Lett (2016) 0.75

The Neurospora crassa CPS-1 polysaccharide synthase functions in cell wall biosynthesis. Fungal Genet Biol (2014) 0.75

Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii. Front Microbiol (2017) 0.75

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev (1995) 8.81

Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun (1992) 5.27

Cryptococcus neoformans. I. Nonencapsulated mutants. J Bacteriol (1967) 5.15

Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol (1993) 5.14

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother (1997) 4.87

The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science (2005) 4.74

A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci U S A (2001) 4.69

Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22

Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol (1990) 3.91

A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology (2002) 3.58

Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol (1982) 2.96

Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci U S A (2002) 2.29

A new dominant selectable marker for use in Cryptococcus neoformans. Med Mycol (2001) 2.16

Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res (1990) 2.08

RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence. Mol Microbiol (2004) 2.06

Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol Microbiol (2003) 2.00

The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect Immun (1993) 1.96

Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice. Infect Immun (1980) 1.88

Improved method of hexosamine determination. Anal Biochem (1971) 1.84

The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol Microbiol (2003) 1.81

The Cryptococcus neoformans STE12alpha gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific. Mol Microbiol (1997) 1.79

The occurrence of alpha(1-3)glucan in Cryptococcus, Schizosaccharomyces and Polyporus species, and its hydrolysis by a Streptomyces culture filtrate lysing cell walls of Cryptococcus. Biochim Biophys Acta (1968) 1.78

A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot Cell (2005) 1.76

Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res (1998) 1.72

The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol (2002) 1.72

A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol (1999) 1.65

Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64

Caspofungin: the first in a new class of antifungal agents. Drug Resist Updat (2003) 1.62

Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun (1994) 1.57

Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol (2006) 1.52

The partial acid hydrolysis of a highly dextrorotatory fragment of the cell wall of Aspergillus niger. Isolation of the alpha-(1-3)-linked dextrin series. Biochem J (1965) 1.51

Transmission electron microscopy of yeast. Microsc Res Tech (2000) 1.44

Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol (2004) 1.39

Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans. J Immunol (2000) 1.39

Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis. Genetics (2001) 1.38

Identification of a putative alpha-glucan synthase essential for cell wall construction and morphogenesis in fission yeast. Proc Natl Acad Sci U S A (1998) 1.36

Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection. Infect Immun (2005) 1.33

A genomic approach for the identification and classification of genes involved in cell wall formation and its regulation in Saccharomyces cerevisiae. Comp Funct Genomics (2001) 1.31

Fission yeast alpha-glucan synthase Mok1 requires the actin cytoskeleton to localize the sites of growth and plays an essential role in cell morphogenesis downstream of protein kinase C function. J Cell Biol (1999) 1.31

Gene prediction and verification in a compact genome with numerous small introns. Genome Res (2004) 1.30

Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol Microbiol (2001) 1.29

Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother (2005) 1.28

Antisense repression in Cryptococcus neoformans as a laboratory tool and potential antifungal strategy. Microbiology (2002) 1.23

AGS3, an alpha(1-3)glucan synthase gene family member of Aspergillus fumigatus, modulates mycelium growth in the lung of experimentally infected mice. Fungal Genet Biol (2006) 1.15

An alpha-1,3-mannosyltransferase of Cryptococcus neoformans. J Biol Chem (2003) 1.14

Role of the conserved Lys-X-Gly-Gly sequence at the ADP-glucose-binding site in Escherichia coli glycogen synthase. J Biol Chem (1993) 1.13

Highly thermostable endo-1,3-beta-glucanase (laminarinase) LamA from Thermotoga neapolitana: nucleotide sequence of the gene and characterization of the recombinant gene product. Microbiology (1997) 1.13

Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun (2005) 1.13

Two alpha(1-3) glucan synthases with different functions in Aspergillus fumigatus. Appl Environ Microbiol (2005) 1.11

A 1,3-beta-glucanosyltransferase isolated from the cell wall of Aspergillus fumigatus is a homologue of the yeast Bgl2p. Microbiology (1998) 1.11

Echinocandin antifungals: review and update. Expert Rev Anti Infect Ther (2006) 1.10

The linkage of (1-3)-beta-glucan to chitin during cell wall assembly in Saccharomyces cerevisiae. Yeast (1994) 1.07

Two glutathione peroxidases in the fungal pathogen Cryptococcus neoformans are expressed in the presence of specific substrates. Microbiology (2005) 1.06

The structure of cell wall alpha-glucan from fission yeast. Glycobiology (2004) 1.00

Characterization and behaviour of alpha-glucan synthase in Schizosaccharomyces pombe as revealed by electron microscopy. Yeast (2003) 0.96

Synthesis of alpha-glucans in fission yeast spores is carried out by three alpha-glucan synthase paralogues, Mok12p, Mok13p and Mok14p. Mol Microbiol (2006) 0.91

The art of serendipity: killing of Caenorhabditis elegans by human pathogens as a model of bacterial and fungal pathogenesis. Expert Rev Anti Infect Ther (2003) 0.90

The pursuit of cryptococcal pathogenesis: heterologous hosts and the study of cryptococcal host-pathogen interactions. FEMS Yeast Res (2006) 0.90

In situ localization of cell wall alpha-1,3-glucan in the fission yeast Schizosaccharomyces pombe. J Electron Microsc (Tokyo) (2003) 0.87

Articles by these authors

Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (2012) 10.53

The marine viromes of four oceanic regions. PLoS Biol (2006) 10.19

Genomewide association study of leprosy. N Engl J Med (2009) 8.17

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature (2005) 7.24

Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res (2002) 4.92

The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science (2005) 4.74

Metagenomic analysis of the microbial community associated with the coral Porites astreoides. Environ Microbiol (2007) 4.21

Pluripotent stem cells from the adult mouse inner ear. Nat Med (2003) 3.92

Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation (2013) 3.91

Google trends: a web-based tool for real-time surveillance of disease outbreaks. Clin Infect Dis (2009) 3.90

FLO1 is a variable green beard gene that drives biofilm-like cooperation in budding yeast. Cell (2008) 3.76

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology (2006) 3.46

Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science (2013) 3.17

Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11

Preoperative aspirin use and outcomes in cardiac surgery patients. Ann Surg (2012) 3.03

A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature (2008) 3.00

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation (2010) 2.95

Viral and microbial community dynamics in four aquatic environments. ISME J (2010) 2.95

A survey on gas sensing technology. Sensors (Basel) (2012) 2.79

Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis (2009) 2.72

Biodiversity and biogeography of phages in modern stromatolites and thrombolites. Nature (2008) 2.70

Retracted Human immunodeficiency virus infection and the thyroid. Thyroid (2002) 2.68

SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem (2005) 2.64

A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell (2003) 2.59

Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol (2006) 2.57

Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). Chem Rev (2013) 2.38

Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A (2009) 2.35

Enhanced salt tolerance mediated by AtHKT1 transporter-induced Na unloading from xylem vessels to xylem parenchyma cells. Plant J (2005) 2.34

Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity (2013) 2.20

Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. Kidney Int (2009) 2.19

Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer. J Natl Cancer Inst (2003) 2.18

Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int (2012) 2.12

Medically important bacterial-fungal interactions. Nat Rev Microbiol (2010) 2.10

Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog (2007) 2.05

Mutation analysis of the MVK gene in Chinese patients with disseminated superficial actinic porokeratosis. J Dermatol Sci (2013) 2.04

Characterization of the bell-shaped vibratory angular rate gyro. Sensors (Basel) (2013) 2.04

Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Sci Transl Med (2013) 2.03

Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol Microbiol (2003) 2.00

Singularity in polarization: rewiring yeast cells to make two buds. Cell (2009) 2.00

The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site. Nat Struct Mol Biol (2010) 1.98

Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen. Infect Immun (2005) 1.96

Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun (2002) 1.96

Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet (2011) 1.95

Septin ring assembly involves cycles of GTP loading and hydrolysis by Cdc42p. J Cell Biol (2002) 1.94

Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiat Oncol Biol Phys (2007) 1.89

Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence (2010) 1.88

A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell (2006) 1.88

Metagenomic analysis indicates that stressors induce production of herpes-like viruses in the coral Porites compressa. Proc Natl Acad Sci U S A (2008) 1.86

Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother (2009) 1.86

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med (2009) 1.84

Three-dimensional arrangement of F-actin in the contractile ring of fission yeast. J Cell Biol (2007) 1.82

Generation of hair cells by stepwise differentiation of embryonic stem cells. Proc Natl Acad Sci U S A (2003) 1.81

Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death. J Am Coll Cardiol (2011) 1.80

Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine (2004) 1.74

Legionella pneumophila DotU and IcmF are required for stability of the Dot/Icm complex. Infect Immun (2004) 1.73

Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J Biol Chem (2002) 1.73

Sustainable power generation in microbial fuel cells using bicarbonate buffer and proton transfer mechanisms. Environ Sci Technol (2007) 1.72

Antibacterial bioagents based on principles of bacteriophage biology: an overview. Clin Infect Dis (2013) 1.70

Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol (2003) 1.70

X-ray phase-attenuation duality and phase retrieval. Opt Lett (2005) 1.68

1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol (2011) 1.67

Research on bell-shaped vibratory angular rate gyro's character of resonator. Sensors (Basel) (2013) 1.66

A new theory of phase-contrast x-ray imaging based on Wigner distributions. Med Phys (2004) 1.66

Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase. Proc Natl Acad Sci U S A (2010) 1.65

A Bi2 WO6 -based hybrid photocatalyst with broad spectrum photocatalytic properties under UV, visible, and near-infrared irradiation. Adv Mater (2013) 1.65

Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol (2011) 1.65

The chromatin-remodeling BAF complex mediates cellular antiviral activities by promoter priming. Mol Cell Biol (2004) 1.64

Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol (2010) 1.64

Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun (2006) 1.63

The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studies. Crit Care Med (2014) 1.61

Anesthetic preconditioning combined with postconditioning offers no additional benefit over preconditioning or postconditioning alone. Anesth Analg (2007) 1.58

In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol (2009) 1.58

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56

Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus. Nat Rev Microbiol (2006) 1.56

Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog (2007) 1.55

Construction of genetic linkage maps and comparative genome analysis of catfish using gene-associated markers. Genetics (2009) 1.55

Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Ann Surg Oncol (2008) 1.55

Adjacent positioning of cellular structures enabled by a Cdc42 GTPase-activating protein-mediated zone of inhibition. J Cell Biol (2007) 1.54

Quality assessment parameters for EST-derived SNPs from catfish. BMC Genomics (2008) 1.54

A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells (2007) 1.53

Clinical implementation of x-ray phase-contrast imaging: theoretical foundations and design considerations. Med Phys (2003) 1.53

A nonproton ligand sensor in the acid-sensing ion channel. Neuron (2010) 1.52

Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun (2004) 1.52

Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol (2006) 1.52

Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses. Cancer Res (2007) 1.51

Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci U S A (2008) 1.51

Loss of melanopsin-containing retinal ganglion cells in a rat glaucoma model. Chin Med J (Engl) (2008) 1.48

Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol (2011) 1.46

Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China. J Clin Microbiol (2005) 1.46

Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects. Breast Cancer Res Treat (2010) 1.46

Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells (2013) 1.46

Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell (2004) 1.45

Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med (2010) 1.45

Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect (2007) 1.44

Surface maturation scoring for oesophageal squamous intraepithelial neoplasia: a novel diagnostic approach inspired by first endomicroscopic 3-dimensional reconstruction. Gut (2012) 1.44

Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett (2007) 1.43

Generation of genome-scale gene-associated SNPs in catfish for the construction of a high-density SNP array. BMC Genomics (2011) 1.43

New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis (2006) 1.42

Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells. Transplantation (2015) 1.41